Asiri Surgical Hospital PLC (COSE:AMSL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Asiri Surgical Hospital Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7,862 | 7,722 | 7,182 | 6,620 | 5,635 | 5,838 | |
Revenue Growth | 6.48% | 7.51% | 8.49% | 17.48% | -3.48% | 38.02% |
Cost of Revenue | 4,455 | 4,228 | 4,181 | 3,950 | 3,405 | 3,378 |
Gross Profit | 3,407 | 3,494 | 3,001 | 2,670 | 2,229 | 2,460 |
Selling, General & Admin | 2,221 | 2,274 | 2,376 | 2,236 | 1,274 | 1,042 |
Operating Expenses | 2,221 | 2,274 | 2,376 | 2,236 | 1,274 | 1,042 |
Operating Income | 1,186 | 1,219 | 625.01 | 433.92 | 954.96 | 1,418 |
Interest Expense | -334.27 | -269.68 | -338.39 | -615.62 | -947.73 | -247.04 |
Interest & Investment Income | 709.55 | 575.89 | 559.27 | 767.97 | 1,218 | 247.39 |
Currency Exchange Gain (Loss) | - | 1.14 | 3.9 | 8.22 | 5.17 | -8.01 |
Other Non Operating Income (Expenses) | 74.33 | 93.04 | 43.4 | 43.82 | 30.8 | 53.34 |
EBT Excluding Unusual Items | 1,636 | 1,620 | 893.19 | 638.31 | 1,261 | 1,464 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.43 | 7.08 |
Gain (Loss) on Sale of Assets | - | -1.91 | -0.01 | -0.02 | -0.44 | -0.67 |
Pretax Income | 1,636 | 1,618 | 893.18 | 638.29 | 1,261 | 1,470 |
Income Tax Expense | 636.08 | 677.45 | 519.46 | 515.28 | 621.37 | 223.6 |
Earnings From Continuing Operations | 999.84 | 940.47 | 373.73 | 123.01 | 640.03 | 1,246 |
Minority Interest in Earnings | -152.47 | -126.41 | -108.06 | -91.46 | -84.91 | -61.62 |
Net Income | 847.37 | 814.05 | 265.67 | 31.55 | 555.12 | 1,185 |
Net Income to Common | 847.37 | 814.05 | 265.67 | 31.55 | 555.12 | 1,185 |
Net Income Growth | 199.66% | 206.42% | 742.03% | -94.32% | -53.14% | 44.10% |
Shares Outstanding (Basic) | 528 | 528 | 528 | 528 | 528 | 528 |
Shares Outstanding (Diluted) | 528 | 528 | 528 | 528 | 528 | 528 |
Shares Change | -0.32% | - | - | - | - | - |
EPS (Basic) | 1.61 | 1.54 | 0.50 | 0.06 | 1.05 | 2.24 |
EPS (Diluted) | 1.61 | 1.54 | 0.50 | 0.06 | 1.05 | 2.24 |
EPS Growth | 200.62% | 206.42% | 742.03% | -94.32% | -53.14% | 44.10% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 89.71 | -95.42 | -435.07 | 98.98 | 248.36 | 863.27 |
Free Cash Flow Per Share | 0.17 | -0.18 | -0.82 | 0.19 | 0.47 | 1.63 |
Dividend Per Share | - | - | 0.300 | - | - | 2.100 |
Dividend Growth | - | - | - | - | - | 147.06% |
Gross Margin | 43.34% | 45.25% | 41.79% | 40.33% | 39.56% | 42.13% |
Operating Margin | 15.09% | 15.79% | 8.70% | 6.55% | 16.95% | 24.29% |
Profit Margin | 10.78% | 10.54% | 3.70% | 0.48% | 9.85% | 20.29% |
Free Cash Flow Margin | 1.14% | -1.24% | -6.06% | 1.49% | 4.41% | 14.79% |
EBITDA | 1,594 | 1,626 | 1,015 | 845.31 | 1,298 | 1,736 |
EBITDA Margin | 20.28% | 21.05% | 14.13% | 12.77% | 23.03% | 29.74% |
D&A For EBITDA | 407.78 | 406.13 | 389.79 | 411.39 | 342.75 | 318.43 |
EBIT | 1,186 | 1,219 | 625.01 | 433.92 | 954.96 | 1,418 |
EBIT Margin | 15.09% | 15.79% | 8.70% | 6.55% | 16.95% | 24.29% |
Effective Tax Rate | 38.88% | 41.87% | 58.16% | 80.73% | 49.26% | 15.21% |
Advertising Expenses | - | 15.24 | 21.81 | 26.42 | 26.35 | 25.14 |